Assessment of Long-Term Hematologic Effects in Differentiated Thyroid Cancer Patients Treated with Radioactive Iodine

Assessment of Long-Term Hematologic Effects in Differentiated Thyroid Cancer Patients Treated with Radioactive Iodine

Objective: Radioactive iodine (RAI) therapy may cause hematologic abnormalities. The aim of this study is to evaluate long-term hematologic effects in differentiated thyroid cancer (DTC) patients after RAI therapy. Materials and Methods: A total of 1389 patients with DTC who were treated with RAI we...

Full description

Bibliographic Details
Main Authors:	Bircan Sönmez, Özlen Bektaş, Nergiz Erkut, Mehmet Sönmez
Format:	Article
Language:	English
Published:	Galenos Publishing House 2021-12-01
Series:	Turkish Journal of Hematology
Subjects:	radioactive iodine thyroid cancer cytopenia hematologic malignancy long-term hematologic effects thrombocytopenia neutropenia
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-39225

Similar Items

The changes in complete blood count in thyroid cancer patients treated with radioactive iodine ablation therapy
by: Bircan Sönmez, et al.
Published: (2010-12-01)

The changes in complete blood count in thyroid cancer patients treated with radioactive iodine ablation therapy
by: Bircan Sönmez, et al.
Published: (2010-12-01)

The Evaluation of Febrile Neutropenic Episodes in Patients with Hematologic Malignancies
by: Kemalettin AYDIN, et al.
Published: (2007-06-01)

COVID-19 in Patients with Hematologic Diseases
by: Ilaria Carola Casetti, et al.
Published: (2022-11-01)

Association between radioactive iodine uptake and neutropenia in untreated Graves’ disease
by: Qian Yang, et al.
Published: (2023-01-01)

Evaluation of Febrile Neutropenia in Hematologic Malignancy Patients
by: Müge ASLAN, et al.
Published: (2014-12-01)

Thrombocytopenic patients with hematological malignancy who underwent fiberoptic bronchoscopy are they really under a significant hemorrhagic risk?
by: Fatih Yıldırım, et al.
Published: (2022-05-01)

Hemorrhagic Pneumonia Caused by <i>Stenotrophomonas maltophilia</i> in Patients with Hematologic Malignancies—A Systematic Review and Meta-Analysis
by: Chienhsiu Huang, et al.
Published: (2024-01-01)

EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA
by: Cumali Yalçın, et al.
Published: (2022-04-01)

The utility of low-iodine diet in preparation for thyroid cancer therapy with radioactive iodine—A cohort study
by: Hongxiu Luo, et al.
Published: (2022-09-01)

Acute myeloid leukemia following radioactive iodine therapy for papillary carcinoma of the thyroid
by: Jain Ankit, et al.
Published: (2009-06-01)

Predictive Role of Serum Thyroglobulin after Surgery and before Radioactive Iodine Therapy in Patients with Thyroid Carcinoma
by: Alberto Signore, et al.
Published: (2023-05-01)

Anaplastic Thyroid Carcinoma Following Radioactive Iodine Therapy for Graves' Disease
by: Sun Hwa Kim, et al.
Published: (2013-03-01)

Low Iodine Diet for Preparation for Radioactive Iodine Therapy in Differentiated Thyroid Carcinoma in Korea
by: Jae Hoon Chung
Published: (2013-09-01)

Tyrosine Kinase Inhibitors for Radioactive Iodine Refractory Differentiated Thyroid Cancer
by: Christos Cortas, et al.
Published: (2023-12-01)

The effect of per os vs subcutaneous 123iodine administration on percentage thyroidal radioactive iodine uptake in normal cats
by: Kevin Cosford, et al.
Published: (2021-11-01)

Management of hyperthyroidism with radioactive iodine
by: T Premprapha, et al.
Published: (2006-08-01)

Cytopenias following anti-CD19 chimeric antigen receptor (CAR) T cell therapy: a systematic analysis for contributing factors
by: Yuan Xia, et al.
Published: (2022-12-01)

Use of cefepime, meropenem, or piperacillin/tazobactam as initial treatment for febrile neutropenia in patients with hematological malignancy — a real-life experience
by: Najmul Karim, et al.
Published: (2022-08-01)

Radioactive Iodine Treatment and the Risk of Long-Term Cardiovascular Morbidity and Mortality in Thyroid Cancer Patients: A Nationwide Cohort Study
by: Chun-Hao Kao, et al.
Published: (2021-09-01)

Secondary Infections in Cancer Patients with Febrile Neutropenia
by: Alpay Azap, et al.
Published: (2012-08-01)

Hematological Abnormalities and Associated Factors Among Patients with Hypothyroidism at the University of Gondar Comprehensive Specialized Hospital
by: Berta DM, et al.
Published: (2024-03-01)

Radioactive iodine in low- to intermediate-risk papillary thyroid cancer
by: Hengqiang Zhao, et al.
Published: (2022-08-01)

Efficacy of Combination Therapy with Lenvatinib and Radioactive Iodine in Thyroid Cancer Preclinical Model
by: Kensuke Suzuki, et al.
Published: (2022-08-01)

Effect of Psychological Intervention on Differentiated Thyroid Cancer Patients in the Treatment with Radioactive Iodine
by: Liu YB, et al.
Published: (2023-03-01)

Changes in Gut Microbiota and Metabolites in Papillary Thyroid Carcinoma Patients Following Radioactive Iodine Therapy
by: Li W, et al.
Published: (2023-10-01)

Febrile Neutropenia in Hematological Malignancies: Clinical and Microbiological Profile and Outcome in High Risk Patients
by: Kuntegowdanahalli C Lakshmaiah, et al.
Published: (2015-07-01)

Sarcoidosis mimicking metastatic thyroid cancer following radioactive iodine therapy
by: Zin W. Myint, et al.
Published: (2015-02-01)

Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode
by: Aslıhan Demirel, et al.
Published: (2015-07-01)

Carbamazepine and Hematological Malignancies
by: İrfan Yavaşoğlu, et al.
Published: (2013-12-01)

Diagnosis of hypersplenism with the epinephrine stimulation test
by: B Misselwitz, et al.
Published: (2012-01-01)

Comparing the efficacy of thyroglobulin and thyroglobulin/ thyroid-stimulating hormone ratio models in predicting a successful response to radioactive iodine therapy
by: Yanli Ju, et al.
Published: (2023-01-01)

Targeting GLI1 Transcription Factor for Restoring Iodine Avidity with Redifferentiation in Radioactive-Iodine Refractory Thyroid Cancers
by: Ji Min Oh, et al.
Published: (2022-03-01)

Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009–2019)
by: Halima El Omri, et al.
Published: (2024-01-01)

Urinary iodine excretion after using povidone iodine or chlorhexidine gluconate for topical disinfectant in patients undergoing thyroidectomy due to thyroid carcinoma: When to do radio active iodine therapy?
by: Soheila Shokrollahi Yancheshmeh, et al.
Published: (2023-01-01)

Effect of liver dysfunction on outcome of radioactive iodine therapy for Graves’ disease
by: Yuyang Ze, et al.
Published: (2022-12-01)

Analysis of the Correlation between the Radioactive Iodine Activity and Neutrophil-to-Lymphocyte Ratio in Patients with Differentiated Thyroid Cancer
by: Adina Elena Stanciu, et al.
Published: (2022-04-01)

Mitigating Effect of 1-Palmitoyl-2-Linoleoyl-3-Acetyl-Rac-Glycerol (PLAG) on a Murine Model of 5-Fluorouracil-Induced Hematological Toxicity
by: Jinseon Jeong, et al.
Published: (2019-11-01)

The efficacy and safety in radioactive iodine refractory thyroid cancer patients treated with sorafenib
by: Yuanna Ling, et al.
Published: (2023-07-01)

Trends in radioactive iodine treatment after total thyroidectomy in Italy, 2001–2018
by: Luigino Dal Maso, et al.
Published: (2023-07-01)